跳至主要内容
临床试验/CTRI/2022/01/039677
CTRI/2022/01/039677尚未招募3 期

Interventional study to determine efficacy, safety and immunogenicity of booster dose of ChAdOx1 nCoV-19 (COVISHIELD) Coronavirus Disease (COVID-19) vaccine in vaccine recipients.- A single centre, randomised control trial - COVIBOOST

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Healthy volunteers above 18 years who have received 2 doses of ChAdOx1 nCoV-19 vaccine
  • Able and willing to comply with study requirements
  • Willing to refrain from blood donation during the study period
  • giving consent

排除标准

  • Anaphylactic reaction following administration of vaccine previously
  • Pregnant or lactating women
  • Any adverse event that in the opinion of the Investigator may affect the safety of the participant or the interpretation of the study results
  • Subject not giving consent
  • Individuals who have received any other COVID1-9 vaccine

研究者

相似试验